Benefits of contrast-enhanced SWI in patients with glioblastoma multiforme

European Radiology

Volumn 23, Issue 10, 2013, Pages 2868-2879

  Fahrendorf, Delia ^a   Schwindt, Wolfram ^a   Wölfer, Johannes ^a   Jeibmann, Astrid ^a   Kooijman, Hendrik ^b   Kugel, Harald ^a   Grauer, Oliver ^a   Heindel, Walter ^a   Hesselmann, Volker ^a   Bink, Andrea ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b PHILIPS HEALTHCARE   (United States)

Author keywords

CIPS; Contrast enhanced SWI; Glioblastoma multiforme; ITSS; Tumour invasion zone

Indexed keywords

GADOBUTROL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CORRELATION COEFFICIENT; FEMALE; GLIOBLASTOMA; HISTOLOGY; HUMAN; IMAGE ANALYSIS; KRUSKAL WALLIS TEST; MALE; PRIORITY JOURNAL; SIGNAL PROCESSING; SUSCEPTIBILITY WEIGHTED IMAGING; TUMOR BIOPSY; TUMOR INVASION; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; ALGORITHMS; BRAIN NEOPLASMS; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GLIOBLASTOMA; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84884813915     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-013-2895-x     Document Type: Article

References (27)

1. Rauscher A, Sedlacik J, Deistung A, Mentzel HJ, Reichenbach JR (2006) Susceptibility weighted imaging: data acquisition, image reconstruction and clinical applications. Z Med Phys 16:240-250
2. Haacke EM, Mittal S, Wu Z, Neelavalli J, Cheng YC (2009) Susceptibility-weighted imaging: technical aspects and clinical applications, part 1. AJNR Am J Neuroradiol 30:19-30
3. Haacke EM, Xu Y, Cheng YC, Reichenbach JR (2004) Susceptibility weighted imaging (SWI). Magn Reson Med 52:612-618
4. Barnes SR, Haacke EM (2009) Susceptibility-weighted imaging: clinical angiographic applications. Magn Reson Imaging Clin N Am 17:47-61
5. Haacke EM, DelProposto ZS, Chaturvedi S et al (2007) Imaging cerebral amyloid angiopathy with susceptibility-weighted imaging. AJNR Am J Neuroradiol 28:316-317
6. Mittal S, Wu Z, Neelavalli J, Haacke EM (2009) Susceptibility-weighted imaging: technical aspects and clinical applications, part 2. AJNR Am J Neuroradiol 30:232-252
7. Sehgal V, Delproposto Z, Haacke EM et al (2005) Clinical applications of neuroimaging with susceptibility-weighted imaging. J Magn Reson Imaging 22:439-450
8. El-Koussy M, Schenk P, Kiefer C et al (2012) Susceptibility-weighted imaging of the brain: does gadolinium administration matter? Eur J Radiol 81:272-276
9. Sehgal V, Delproposto Z, Haddar D et al (2006) Susceptibility-weighted imaging to visualize blood products and improve tumor contrast in the study of brain masses. J Magn Reson Imaging 24:41-51
10. Kim HS, Jahng GH, Ryu CW, Kim SY (2009) Added value and diagnostic performance of intratumoral susceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study. AJNR Am J Neuroradiol 30:1574-1579
11. Li C, Ai B, Li Y, Qi H, Wu L (2009) Susceptibility-weighted imaging in grading brain astrocytomas. Eur J Radiol 75:e81-e85
12. Park MJ, Kim HS, Jahng GH, Ryu CW, Park SM, Kim SY (2009) Semiquantitative assessment of intratumoral susceptibility signals using non-contrast-enhanced high-field high-resolution susceptibility-weighted imaging in patients with gliomas: comparison with MR perfusion imaging. AJNR Am J Neuroradiol 30:1402-1408
13. Pinker K, Noebauer-Huhmann IM, Stavrou I et al (2007) High-resolution contrast-enhanced, susceptibility-weighted MR imaging at 3T in patients with brain tumors: correlation with positron-emission tomography and histopathologic findings. AJNR Am J Neuroradiol 28:1280-1286
14. Hori M, Ishigame K, Kabasawa H et al (2010) Precontrast and postcontrast susceptibility-weighted imaging in the assessment of intracranial brain neoplasms at 1.5 T. Jpn J Radiol 28:299-304
15. Brokinkel B, Fischer BR, Peetz-Dienhart S et al (2010) MGMT promoter methylation status in anaplastic meningiomas. J Neurooncol 100:489-490
16. Liu G, Sobering G, Duyn J, Moonen CT (1993) A functional MRI technique combining principles of echo-shifting with a train of observations (PRESTO). Magn Reson Med 30:764-768
17. Pichlmeier U, Bink A, Schackert G, Stummer W (2008) Resection and survival in glioblastoma multiforme: an RTOG recursive partitioning analysis of ALA study patients. Neuro Oncol 10:1025-1034
18. Pedraza S, Puig J, Blasco G et al (2012) Reliability of the ABC/2 method in determining acute infarct volume. J Neuroimaging 22:155-159
19. Barth M, Nobauer-Huhmann IM, Reichenbach JR et al (2003) High-resolution three-dimensional contrast-enhanced blood oxygenation level-dependent magnetic resonance venography of brain tumors at 3 Tesla: first clinical experience and comparison with 1.5 Tesla. Invest Radiol 38:409-414
20. Holash J, Maisonpierre PC, Compton D et al (1999) Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 284:1994-1998
21. Holash J, Wiegand SJ, Yancopoulos GD (1999) New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18:5356-5362
22. Matsukado Y, Maccarty CS, Kernohan JW (1961) The growth of glioblastoma multiforme (astrocytomas, grades 3 and 4) in neurosurgical practice. J Neurosurg 18:636-644
23. Sampetrean O, Saga I, Nakanishi M et al (2011) Invasion precedes tumor mass formation in a malignant brain tumor model of genetically modified neural stem cells. Neoplasia 13:784-791
24. Wu Z, Mittal S, Kish K, Yu Y, Hu J, Haacke EM (2009) Identification of calcification with MRI using susceptibility-weighted imaging: a case study. J Magn Reson Imaging 29:177-182
25. Zhu WZ, Qi JP, Zhan CJ et al (2008) Magnetic resonance susceptibility weighted imaging in detecting intracranial calcification and hemorrhage. Chin Med J (Engl) 121:2021-2025
26. Al Sayyari A, Buckley R, McHenery C, Pannek K, Coulthard A, Rose S (2010) Distinguishing recurrent primary brain tumor from radiation injury: a preliminary study using a susceptibility-weighted MR imaging-guided apparent diffusion coefficient analysis strategy. AJNR Am J Neuroradiol 31:1049-1054
27. Lupo JM, Chuang CF, Chang SM et al (2012) 7-Tesla susceptibility-weighted imaging to assess the effects of radiotherapy on normal-appearing brain in patients with glioma. Int J Radiat Oncol Biol Phys 82:e493-e500